<DOC>
	<DOCNO>NCT00662454</DOCNO>
	<brief_summary>The purpose blood spot validation portion study test measure female hormone level blood accurate finger stick , blood draw vein . The purpose feasibility study evaluate ovulation occurrence two population oral contraceptive user : heavy light woman .</brief_summary>
	<brief_title>Oral Contraceptive Efficacy Body Weight</brief_title>
	<detailed_description>The blood spot validation portion study test hypothesis progesterone assay self-collected daily blood spot equivalent serum sample , value obtain identify woman ovulate . After validate collection method , enrollment begin feasibility portion study look thin heavy woman birth control pill . All woman portion study take very-low dose birth control pill normally available doctor 's office . During month study , woman blood pressure weight record , blood drawn twice per week use finger stick kit daily home check natural hormone brain chemical tell egg develop . During last week menstrual cycle ( period week ) , woman also blood drawn measure level hormone find birth control pill . Women also need report write diary take birth control pill day .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>age 18 35 single baseline hematocrit â‰¥ 36 % single progesterone level 3 ng/mL great luteal phase ( day 18 25 ) menstrual cycle prior treatment OCs . absolute contraindication ethinyl estradiol levonorgestrel smoking actively seek involved weight loss program ( must weight stable ) pregnancy , breastfeeding , seek pregnancy diagnosis Polycystic Ovarian Syndrome recent ( 8 week ) use OC ( patch ring include ) , intrauterine , implantable hormonal contraception DepoProvera use within six month current use drug interfere metabolism sex steroid .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>contraceptive</keyword>
	<keyword>efficacy</keyword>
	<keyword>body weight</keyword>
</DOC>